Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 10:02 PM
Study NCT ID:
NCT01133158
Status:
COMPLETED
Last Update Posted:
2018-11-01
First Post:
2010-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial
Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
R-BMD GELTAMO 08
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None